Medtronic Inc.
710 Medtronic Parkway
Minneapolis,
MN 55432
Phone: 763-514-4000
Fax: 763-514-4879
Web Site: http://www.medtronic.com
| Medtronic, Inc. engages in the development, manufacture, and marketing of medical devices worldwide. The company's Cardiac Rhythm Disease Management segment offers implantable devices, leads, ablation products, electrophysiology catheters, and information systems for cardiac rhythm diseases. Its Spinal and Navigation segment provides thoracolumbar, cervical, and interbody devices; bone growth substitutes; and surgical navigation tools. The company's Vascular segment offers coronary, endovascular, and peripheral stents and related delivery systems; stent graft systems; distal embolic protection systems; and balloon angioplasty catheters, guidewires, guide and diagnostic catheters, and accessories to treat coronary artery disease, aortic and thoracic aneurysms, and peripheral vascular disease. The company's Diabetes segment provides external insulin pumps and related consumables, glucose monitoring systems, and subcutaneous glucose sensors to treat diabetes. Its Cardiac Surgery segment offers perfusion systems; positioning and stabilization systems; and products for the repair and replacement of heart valves, surgical accessories, and surgical ablation products. The company's ENT segment provides tissue-removal systems and other surgical instruments, implantable devices, nerve monitoring systems, disposable fluid-control products, image-guided surgery systems, and Meniere's disease therapy device. Its Physio-Control segment offers external defibrillation and emergency response systems. Medtronic sells its products to hospitals, clinics, third party healthcare providers, and governmental healthcare programs and group purchasing organizations. The company was founded in 1949 and is headquartered in Minneapolis, Minnesota. |
|
| Key Statistics |
|
|
|
| |
Pay |
Exercised |
Mr. Arthur D. Collins Jr., 59
Exec. Chairman
|
$
2.30M |
$
2.39M |
Mr. William A. Hawkins III, 53
Chief Exec. Officer, Pres
|
N/A
|
N/A |
Mr. Gary L. Ellis , 50
Chief Financial Officer, Principal Accounting Officer and Sr. VP
|
$
820.00K |
N/A |
Mr. Michael F. DeMane , 51
Chief Operating Officer
|
$
1.06M |
$
1.49M |
Mr. Stephen H. Mahle , 61
Exec. VP, Sr. Healthcare Policy Advisor and Pres of Cardiac Rhythm Disease Management
|
$
814.00K |
$
1.68M |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
|
|
|
Help
Profile
